Friday, 23 Aug 2019

You are here

The RheumNow Week in Review - 27 October 2017

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. In this week's report, Dr. Jack Cush discusses weight loss and nonadherence in gout, tofacitinib and atherosclerosis, new FDA approvals for PsA and AS, and biosimilar savings ahead.

  1. Metanalysis of ULT adherence in Gout, 16 studies show adherence 46-48%,higher with elderly and those with DM, HTN or comorbidity https://buff.ly/2y6kOQd
  2. Atherosclerosis assessed by CIMT in 46 RA pts showed tofacitinib to improve CIMT, despite potential to increase lipids. https://t.co/w2myWgYu61
  3. Claims data on RA pts shows better persistence with 581 MOA switchers vs 935 TNFi cyclers (48% v 40%) & lower healthcare costs ($37,804 versus $42,116) https://t.co/4TNQYgMw4f
  4. British psoriasis registry (BADBIR) shows SIE not increased with biologics ETN, ADA, UST (1.4-1.5/100PY) vs nonbiologic 1.4/100py https://t.co/7ZQD65e7W9
  5. ANCA Assoc Vasculitis has increased malignancy risk that has decreased w/ better theatment and less CTX use. https://t.co/4UJBLtt8Wk
  6. Review of 10 wt loss intervention trials in obese or overweight gout pts - 6/8 showed weight loss reduces attacks. https://t.co/pfEAoWwdIR
  7. FDA Approves Simponi Aria for Psoriatic Arthritis and Ankylosing Spondylitis 
  8. Biosimilars Projected to Yield $54 Billion in Savings in the next decade
  9. RABBIT Risk Scores are Higher in ICU-Admitted RA Patients

For ACR Coverage: follow us @RheumNow or #ACR17 on Twitter, daily (M-Th) go to ACR17.rheumnow.com, lookout for our real time twitter polls during the meeting!

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – Upadacitinib FDA Approved for RA (8.23.19)

Dr. Jack Cush reports on the news and journal reports from the past week on RheumNow.com, including: how your genetics may shape your microbiome; GERD as a risk factor for TMJ?; how can MDA-5+ dermatomyositis be any worse; new drug happenings; StillsNow.com; and more.

RheumNow Podcast – Antibiotics Increase RA Risk (8.16.19)

Dr. Jack Cush reports the news and important journal articles from the past week on RheumNow.com.

RheumNow Podcast – Tricked Up Lupus Criteria (8.9.19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including new SLE criteria, ULT in gout and MSU reductions, IVIG in ANCA vasculitis and non-TNF biologics outperform the TNF inhibitors.

EULAR Recommendations on Large Vessel Vasculitis

Th European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) was originally published in 2009. Since then there have been new randomised clinical trials and cohort analyses leading to an update the original recommendations.

RheumNow Podcast – More Than a Spot of Tea (8.2.19)

Dr. Jack Cush reviews the journal articles and news reports from the past week on RheumNow.com: MMP-7 and Myositis-ILD; Post-surgical gout attacks; CV events and testosterone; and a Boxed warning for tofacitinib.